Patients with severe disease showed a 4-fold induction in PTX3 plasma levels compared to those with moderate disease (p < 0.0001) (Table 3; Figure 3A), confirming previously reported results that PTX3 levels are associated with COVID-19 severity.27 This evidence concerns the gene PTX3 and COVID-19.